← Back to Search

Stem Cell Therapy

Stem Cells + Light Therapy for Alzheimer's Disease and Autism (ACIST Trial)

N/A
Waitlist Available
Led By Jeffrey Weiss, MD
Research Sponsored by MD Stem Cells
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have documented cognitive impairment or diagnosis of disease associated with cognitive impairment such as Alzheimer's Disease, Autism Spectrum Disorder.
Have documented cognitive impairment or diagnosis of disease associated with cognitive impairment such as Alzheimer's Disease, Autism Spectrum Disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1,3,6,and 12 months post treatment
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether stem cells from patients' own bone marrow can improve cognitive impairment and socialization issues in adults with Alzheimer's or autism. Near-infrared light therapy will also be tested.

Who is the study for?
This trial is for adults over 18 with cognitive impairments or diagnoses like Alzheimer's, various dementias, Autism Spectrum Disorder, and other brain diseases. They should be stable on current treatments and have potential to benefit from BMSC treatment without significant risk. Pregnant women or those who may become pregnant within 3 months post-treatment are excluded.
What is being tested?
The study tests autologous Bone Marrow Derived Stem Cells (BMSC) administered intravenously and topically through the nose, along with Near Infrared Light therapy. It aims to improve cognitive function in dementia and behavior in adult autism.
What are the potential side effects?
Potential side effects aren't specified but participants must be at minimal risk of harm from BMSC treatment as assessed by investigators. Medical clearance is required indicating they can undergo the procedure safely.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with a condition that affects my thinking, like Alzheimer's or Autism.
Select...
I have been diagnosed with a condition like Alzheimer's or Autism that affects my thinking.
Select...
I am over 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1,3,6,and 12 months post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1,3,6,and 12 months post treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Autism Spectrum Quotient Exam
Mini-Mental Status Exam (MMSE)
Secondary study objectives
Activities of Daily Living

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Active Control
Group I: Arm 1Active Control1 Intervention
Intravenous Bone Marrow Stem Cell (BMSC) Fraction
Group II: Arm 2Active Control2 Interventions
Intravenous Bone Marrow Stem Cell (BMSC) Fraction combined with Near Infrared Light exposure .
Group III: Arm 3Active Control2 Interventions
Intravenous Bone Marrow Stem Cell (BMSC) Fraction combined with Intranasal topical Bone Marrow Stem Cell (BMSC) Fraction.

Find a Location

Who is running the clinical trial?

MD Stem CellsLead Sponsor
5 Previous Clinical Trials
1,390 Total Patients Enrolled
Steven Levy, MDStudy ChairMD Stem Cells
4 Previous Clinical Trials
1,340 Total Patients Enrolled
Jeffrey Weiss, MDPrincipal InvestigatorCoral Springs
4 Previous Clinical Trials
1,340 Total Patients Enrolled

Media Library

Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction (Stem Cell Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT03724136 — N/A
Autism Spectrum Disorder Research Study Groups: Arm 1, Arm 2, Arm 3
Autism Spectrum Disorder Clinical Trial 2023: Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction Highlights & Side Effects. Trial Name: NCT03724136 — N/A
Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction (Stem Cell Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03724136 — N/A
Autism Spectrum Disorder Patient Testimony for trial: Trial Name: NCT03724136 — N/A
~10 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top